tm logo
LCLNP
Live/Pending
PUBLISHED FOR OPPOSITION

on 12 Mar 2024

Last Applicant/ Owned by

Vancouver BC V6T 1Z3

CA

Serial Number

79352347 filed on 18th Jul 2022

Registration Number

N/A

Correspondent Address

Jeffrey A. Smith

Millen, White, Zelano & Branigan, P.C.

2200 Clarendon Boulevard

Suite 1400

Arlington,VA 22201

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

LCLNP

Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for thRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services

Class [005]
Pharmaceutical Products


Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging

Mark Details


Serial Number

No 79352347

Mark Type

No Service Mark

Attorney Docket Number

No LAMV-0004-T

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st Apr 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13th Mar 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
13th Mar 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12th Mar 2024PUBLISHED FOR OPPOSITION
12th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Mar 2024NOTIFICATION PROCESSED BY IB
21st Feb 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21st Feb 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21st Feb 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB